STOK: Stoke Therapeutics, Inc.
Performance
STOK +21.22%
Watchlist
Select an item
Summary
STOK at a glance
STOK returned +21.22% over the past year and +1.30% a year over five years. Its worst drop in that year was -41.33%, smaller than 35% of stocks on Redstone, and its Sharpe ratio of 0.56 beats 54% of stocks on Redstone. It pays no dividends.
Current Drawdown
-27.74%
Rolling Volatility
53.36%
Actions
Metrics
Risk Indicators
Alpha21.50%
Beta0.89x
Sharpe0.56
Sortino0.85
Omega1.10
Calmar0.51
Martin1.60
Profile
About STOK
Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the bodys potential with RNA medicine.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $1.8B
- Listed
- Jun 2019
- Employees
- 170
- Headquarters
- Bedford, MA
- Website
- stoketherapeutics.com
Comparisons